Get the app
US › Healthcare

Accuray Incorporated (ARAY)

US · Healthcare · Medical Devices

$0.24+4.78%
Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue
$100.9M
Revenue YoY
-20.9%
Net profit
$-1.9M
Profit YoY
-272.8%
EPS
$-0.02
EPS estimate
$-0.03
Net margin
-1.9%

EPS came in at -0.02 against a street estimate of -0.03 — a beat of 33.3%.

Key statistics

Market cap
$29.9M
Forward P/E
94.3
P/B
0.72
Book value
$0.35
EPS (TTM)
$-0.40
52-week high
$2.10
52-week low
$0.22
50-day MA
$0.27
200-day MA
$0.50
Beta
1.39

Analyst view

Analysts rate Accuray Incorporated a strong buy (4 buy, 0 hold, 0 sell out of 4) with an average price target of $0.35.

Shareholding

Insiders
4.36%
Institutions
64.49%

Largest institutional holders

FundStake
TCW Group Inc12.95%
BlackRock Inc7.08%
Neuberger Berman Group LLC4.90%
Armistice Capital, LLC4.72%
Weber Capital Management LLC4.13%
Vanguard Capital Management, LLC3.71%
Geode Capital Management, LLC1.99%
Mackenzie Investments1.96%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Accuray Incorporated — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncMerck & Company IncUnitedHealth Group IncorporatedNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncAmgen IncNovo Nordisk A/SGilead Sciences IncAbbott Laboratories

Data updated 2026-09-18.